COLUMBUS, Ohio, Feb. 8, 2018 /PRNewswire/ -- Two Labs, an industry-leading pharma and life science services company,
Two Labs' mission is to improve patients' quality of life by delivering innovative trade and commercialization services to pharmaceutical manufacturers. The MKO acquisition enhances this mission by integrating new capabilities in pricing and market access strategy. The transaction combines two performance-driven organizations that share a commitment to innovation, collaboration and client service.
"The pharmaceutical industry relies on Two Labs to provide commercialization support services so that they can focus on developing new and innovative therapies that enhance patients' lives. The union of Two Labs' and MKO's pharma services expands our total solution suite through the addition of a highly-regarded market access solutions provider," said Rich Wartel, CEO of Two Labs. Wartel continued, "For both organizations, culture matters as much as our solutions. As a result, our clients view us as a strategic partner and an extended part of their team—not as a vendor."
"MKO has enjoyed a 15-year relationship with Two Labs, and we are thrilled to be joining the Two Labs family," stated Steve O'Malley, Partner at MKO Global Partners. O'Malley added, "Each organization views the other as the logical extension toward the total solutions suite for market access, and we believe our clients will be thrilled with the capabilities we will be able to provide through our new partnership. Our clients frequently ask us to provide the additional services that Two Labs offers, just as Two Labs' clients frequently ask them to provide the additional services that we offer."
The transaction was completed as of February 2, 2018. Retention of the MKO San Diego office is an essential part of the integration plan. Terms of the agreement were not disclosed.
About Two Labs
Two Labs is a leading pharmaceutical services company that provides a portfolio of product commercialization and lifecycle services to pharmaceutical manufacturers. Since its inception in 2003, Two Labs has engaged with over 350 pharmaceutical manufacturers, supporting more than 140 product launches and managed more than 60 post-launch products for the trade and supply channel. For more information, visit www.TwoLabs.com.
About MKO Global Partners
MKO Global Partners is a strategic global life sciences consulting firm focused on payer strategy, market access, and pricing to the pharmaceutical and biotech markets. MKO works with clients to develop their global value strategy as well as supporting the implementation of a successful managed care approach. Established in 2015 by founders with 90 years of combined experience and 250 market access engagement, MKO is a trusted pricing and payer strategy partner for clients. For more information, visit www.mkogp.com.
View original content:http://www.prnewswire.com/news-releases/two-labs-acquires-mko-global-partners-300595010.html
SOURCE Two Labs, LLC
Subscribe to our Free Newsletters!
Fallot's tetralogy is a rare and complex birth defect of the heart. Babies born with this condition ...
Bubonic plague is an infectious disease caused by the bacteria Yersinia pestis present in rodents ...
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...View All